Doc for nausea in prgnancy
Reading File
Finding Sources
Searching PubMed
"nausea and vomiting of pregnancy" AND treatment
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have sufficient information to provide a comprehensive answer. Let me compile it all.
Nausea and Vomiting of Pregnancy (NVP) / Morning Sickness
Epidemiology
Nausea and vomiting affects 50-90% of pregnancies, making it one of the most common complaints in obstetric care. Despite the name "morning sickness," only ~2% of women have symptoms restricted to the morning; ~80% are symptomatic throughout the day. Symptoms typically:
-
Begin ~39 days after the last menstrual period
-
Peak at 9-12 weeks' gestation
-
Resolve by 16-22 weeks in most women, though ~45% report persistence into late pregnancy
-
Yamada's Textbook of Gastroenterology, 7th ed.
-
Sleisenger and Fordtran's GI and Liver Disease
Pathogenesis
The exact cause is unknown, but several factors are implicated:
| Factor | Role |
|---|---|
| beta-hCG | Levels parallel symptom severity; stimulates gastric CCK receptors; higher levels in molar pregnancies and multiple gestations = worse NVP |
| Estrogen/Progesterone | May slow gastric emptying |
| Vitamin B6 deficiency | Reduced pyridoxine levels observed in NVP |
| Helicobacter pylori | Serological association with hyperemesis, though fecal antigen studies are inconsistent |
| Serotonin receptor genetics | SNPs in HTR3C gene (rs6806362, rs6807670) associated with NVP, explaining hereditary tendencies |
| Psychological factors | Contribute in some patients |
Risk factors: primigravida, young age, multiple gestation, obesity, low socioeconomic status, underlying GERD, prior NVP, Asian/Middle Eastern ethnicity (for hyperemesis).
Spectrum of Disease
1. Nausea and Vomiting of Pregnancy (NVP / "Morning Sickness")
Mild-to-moderate symptoms without dehydration or nutritional compromise. Generally resolves by 12-16 weeks. Usually benign - actually associated with longer gestation and reduced miscarriage risk, as well as reduced congenital heart defects and cleft lip/palate.
2. Hyperemesis Gravidarum (HG)
Severe, intractable vomiting affecting 0.3-3% of pregnancies. Defined by:
- Intractable vomiting
- Weight loss >5% of pre-pregnancy weight
- Dehydration, ketonuria
- Electrolyte abnormalities (especially hypokalemia)
The most common cause of first-trimester hospitalization in the US (second only to preterm labor).
Serious complications of HG include:
- Wernicke's encephalopathy (thiamine deficiency)
- Osmotic demyelination syndrome
- Mallory-Weiss tears
- Thromboembolism
- Renal insufficiency
- Retinal hemorrhage
- Low birth weight and preterm delivery in the infant
Differential diagnosis must exclude: ectopic pregnancy, appendicitis, cholecystitis, pancreatitis, pyelonephritis, PUD, hepatitis, HELLP syndrome, fatty liver of pregnancy, molar pregnancy.
Workup
For significant vomiting - especially suspected HG:
- CBC, comprehensive metabolic panel (electrolytes, BUN, creatinine)
- Thyroid function (transient gestational hyperthyroidism common with HG)
- Serum lipase
- Urinalysis - look for ketones (early sign of starvation), specific gravity
- Serum beta-hCG - rule out molar pregnancy, assess for multiples
- Pelvic ultrasound - confirm intrauterine pregnancy, evaluate for mole or twins
Treatment - Stepwise Approach
Step 1: Lifestyle & Non-pharmacologic (First-line)
- Small, frequent meals; avoid large meals and known dietary triggers
- Avoid strong odors and fatty/spicy foods
- High-protein snacks may be more effective than dry crackers
- Ginger (500-1000 mg/day orally): multiple RCTs show benefit over placebo; equivalent to pyridoxine in some studies
- Pyridoxine (Vitamin B6): 25 mg every 8 hours PO; first-line, safe in pregnancy
- Acupressure (P6 wristpoint) and acupuncture: evidence supports modest symptomatic benefit
- Thiamine (B1) supplementation: mandatory in prolonged vomiting to prevent Wernicke's encephalopathy
Step 2: Pharmacologic Therapy
| Drug | Class | Dosing | Notes |
|---|---|---|---|
| Doxylamine + Pyridoxine (Diclegis/Diclectin) | H1-antagonist + B6 | 2 tablets (10mg/10mg) nightly; can add AM/PM doses | FDA Category A; first-line Rx; no teratogenicity demonstrated despite prior controversy |
| Promethazine (Phenergan) | Phenothiazine / H1 antagonist | 12.5-25 mg PO/PR/IM/IV every 4h | FDA Cat C; sedation, dystonia risk; avoid IV push (tissue necrosis risk) |
| Prochlorperazine (Compazine) | Phenothiazine | 5-10 mg PO every 3-4h; 25 mg PR every 12h; 10 mg IV over 2 min | Extrapyramidal side effects |
| Metoclopramide (Reglan) | Dopamine antagonist | 10 mg PO/IV every 6-8h | FDA Cat B; higher adverse effect rate (tardive dyskinesia with prolonged use); use cautiously |
| Ondansetron (Zofran) | 5-HT3 antagonist | 4-8 mg PO every 8h; 8 mg IV over 5 min | FDA Cat B; good tolerability, no dystonia; evidence on teratogenicity is insufficient - some concern for cardiac defects in first trimester; many guidelines recommend using other agents first |
| Diphenhydramine (Benadryl) | H1 antagonist | 25-50 mg PO every 6h | FDA Cat B; sedating |
| Chlorpromazine | Phenothiazine | 10-25 mg PO every 4-6h | Less commonly used |
Note: The old FDA pregnancy categories (A, B, C) are shown for historical context; the FDA now uses narrative labeling.
Step 3: IV Fluid Resuscitation (for dehydration/HG)
- IV fluids: 5% glucose in lactated Ringer's or normal saline to correct dehydration and reverse ketonuria
- Hold oral intake initially; restart oral fluids after vomiting controlled
- Replete electrolytes - especially potassium
- Give IV/IM thiamine before dextrose to prevent Wernicke's
Step 4: Refractory HG
- Glucocorticoids (methylprednisolone): for severe, refractory cases not responding to antiemetics
- Enteral nutrition (nasojejunal feeding or jejunostomy): for persistent weight loss
- Parenteral nutrition: last resort; high infection and thromboembolism risk in pregnancy
Admission Criteria
- Uncertain diagnosis
- Intractable vomiting
- Persistent ketones or electrolyte abnormalities after IV fluid trial
- Weight loss >10% of pre-pregnancy weight
- Inability to tolerate oral fluids
Discharge Criteria
- Reversal of ketonuria
- Electrolyte correction
- Successful trial of oral fluids
- Discharge with oral antiemetic prescription (no single drug of choice)
Recent Evidence
Recent systematic reviews (2024-2025) support acupuncture and acupoint-based therapies as adjuncts for NVP [PMID 39214380, PMID 41098990]. A 2025 systematic review highlighted the substantial economic and quality-of-life burden of HG [PMID 40750873], reinforcing the need for early, aggressive management.
Sources: Sleisenger and Fordtran's Gastrointestinal and Liver Disease | Yamada's Textbook of Gastroenterology, 7th ed. | Tintinalli's Emergency Medicine, Comprehensive Study Guide | Katzung's Basic and Clinical Pharmacology, 16th ed.
This is a shared conversation. Sign in to Orris to start your own chat.